-2.32%
Today
Loading 1D prices…
Company profile
Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring majority or full ownership of privately held, established companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy span aerospace, defense, national security (including cybersecurity), and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
Nasdaq
Display currency
USD
Location
MILAN, Italy, United States
Employees
9
CIK
1838716
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ATYRaTyr Pharma Inc. Common Stock | $42.2M | $190K | -39009.47% | -$0.80 | -1.60% | Hold |
| MGXMetagenomi Therapeutics Inc. Common Stock | $43.8M | $25.2M | -348.54% | -$2.36 | 0.00% | Buy |
| ELUTElutia Inc. Class A Common Stock | $35.9M | $12.3M | +434.23% | $0.87 | +1.25% | Buy |
| SCLXScilex Holding Company Common Stock | $35.2M | $30.3M | -1236.42% | -$36.48 | -0.79% | Unrated |
| TVGNTevogen Inc. Common Stock | $47.9M | $0.00 | — | -$8.08 | +0.96% | Unrated |